𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Initial Risk Assessment for Pulmonary Hypertension in Patients with COPD

✍ Scribed by Eric J. Gartman; Michael Blundin; James R. Klinger; Joe Yammine; Mary B. Roberts; F. Dennis McCool

Publisher
Springer
Year
2011
Tongue
English
Weight
249 KB
Volume
190
Category
Article
ISSN
0341-2040

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Nifedipine Treatment for Pulmonary Hyper
Nifedipine Treatment for Pulmonary Hypertension in a Patient with Systemic Sclerosis
✍ Stephen Ocken; Elizabeth Reinitz; Joel Strom πŸ“‚ Article πŸ“… 1983 πŸ› John Wiley and Sons 🌐 English βš– 251 KB πŸ‘ 2 views

The etiology of scleroderma remains unknown. However, it is believed that the vascular lesions found in involved organs have a pathogenesis related to endothelial cell injury (1). Pulmonary hypertension is the most common cause of acute dyspnea in patients with systemic sclerosis and is thought to